Ashesha Mechineni

Dr. Ashesha Mechineni

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2020 in Cureus
Verified
Journal Article
Open access
PDF file
BSBalraj Singh
Balraj Singh
PKParminder Kaur
Parminder Kaur
AMAshesha Mechineni
Ashesha Mechineni
MMMichael Maroules
Michael Maroules
Coronavirus disease 2019 (COVID-19) is a global public health emergency. COVID-19 is most well known for affecting the respiratory system, although it can also result in several extrapulmonary manifestations. Limited literature is available regarding rhabdomyolysis in COVID-19. We report four cases of rhabdomyolysis in COVID-19 patients. High index of suspicion is required for the appropriate clinical scenario to recognize this life-threatening situation so that complications can be avoided

16 August 2021 in Expert Opinion on Drug Safety
Verified
Journal Article
Closed access
AMAshesha Mechineni
Ashesha Mechineni
HKHagar Kassab
Hagar Kassab
RMRajapriya Manickam
Rajapriya Manickam
Remdesivir is a nucleoside analog, which inhibits viral RNA replication by blocking RNA-dependent RNA polymerase. First developed and tested during the Ebola epidemic, repurposed, and gained promin...

1 April 2021 in Hematology, Transfusion and Cell Therapy
Verified
Journal Article
Open access
BSBalraj Singh
Balraj Singh
AMAshesha Mechineni
Ashesha Mechineni
PKParminder Kaur
Parminder Kaur
RRRo-Jay Reid
Ro-Jay Reid
MMMichael Maroules
Michael Maroules

1 October 2020 in Chest
Verified
Journal Article
Open access
PDF file
AMAshesha Mechineni
Ashesha Mechineni
SNSushant Nanavati
Sushant Nanavati
RSRoberto A. Solis
Roberto A. Solis
MIMedhat Ismail
Medhat Ismail
SESSION TITLE: Global Case Report Posters

15 February 2021 in Cureus
Verified
Journal Article
Open access
PDF file
AMAshesha Mechineni
Ashesha Mechineni
BSBalraj Singh
Balraj Singh
RMRajapriya Manickam
Rajapriya Manickam
Swyer-James-Macleod syndrome (SJMS) is a rare clinical entity acquired during childhood due to a respiratory infection leading to bronchiolitis obliterans. This inciting event is hypothesized to cause structural and functional changes of the developing alveoli, terminal bronchioles, and the corresponding pulmonary vasculature, resulting in emphysematous changes and a matched ventilation-perfusion defect. We present a 67-year-old male patient with hypercapnic respiratory failure requiring invasive mechanical ventilation, who had typical features of SJMS undiagnosed before this admission. He was extubated successfully, discharged home, and continues to be stable at a 90-day follow-up period. This marks one of the rare accounts where a patient with SJMS was given ventilatory support emergently, and one of the oldest patients reported. SJMS is under-reported due to its indolent clinical course and misdiagnosed as some other pulmonary abnormality. The clinical course progression and prognosis are unclear and variable in many affected patients due to this condition's rarity.

23 June 2021 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
AMAshesha Mechineni
Ashesha Mechineni
RMRajapriya Manickam
Rajapriya Manickam
BSBalraj Singh
Balraj Singh
Emphysematous cholecystitis is a critical differential diagnosis for physicians to consider when evaluating patients with acute abdomen. Patients who are unable to undergo emergency surgery can benefit from percutaneous cholecystostomy.